Table 2.
BCG vaccination-induced adverse drug reactions (ADR) and mycobacterium infections in XHIGM patients.
| Patients | Ages | Performances | Treatments |
|---|---|---|---|
| P6 | 2 m | BCGitis (ipsilateral axillary lymphadenitis) | Surgery |
|
| |||
| P7 | 2 m | BCGitis (ipsilateral axillary lymphadenitis) | Surgery |
|
| |||
| P12 | 50 d | BCGitis (ipsilateral axillary lymphadenectasis) | Antituberculosis medicine (rifampicin, unregularly) |
| 35 m | Pulmonary tuberculosis | Antituberculosis medicine (isoniazide + rifampicin + VitB6), antibiotics | |
|
| |||
| P16 | 7 m | BCGitis (ipsilateral axillary lymphadenitis) | Surgery |
|
| |||
| P17 | 2 m | BCGitis (ipsilateral axillary lymphadenitis) | Surgery |
|
| |||
| P19 | 3 m | BCGitis (ipsilateral cervical lymphadenectasis) | Antituberculosis medicine |
|
| |||
| P14 | 8.5 y | Pulmonary tuberculosis, restrictive pulmonary capacity, splenomegaly and lymphadenopathy | Antituberculosis medicine (isoniazide + rifampicin, unregularly), antibiotics, IVIG, thymosin |
| 10 y | Tuberculous meningitis | Antituberculosis medicine (isoniazide + rifampicin, unregularly) | |
Note: IVIG: intravenous immunoglobulin.